0001953599-22-000001.txt : 20221108 0001953599-22-000001.hdr.sgml : 20221108 20221108114330 ACCESSION NUMBER: 0001953599-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221108 DATE AS OF CHANGE: 20221108 EFFECTIVENESS DATE: 20221108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Inflection Point Genetics Inc. CENTRAL INDEX KEY: 0001953599 IRS NUMBER: 883949143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-464185 FILM NUMBER: 221367819 BUSINESS ADDRESS: STREET 1: 4340 DUNCAN AVENUE STREET 2: SUITE 278 CITY: ST. LOUIS STATE: MO ZIP: 63110 BUSINESS PHONE: 314-615-6355 MAIL ADDRESS: STREET 1: 4340 DUNCAN AVENUE STREET 2: SUITE 278 CITY: ST. LOUIS STATE: MO ZIP: 63110 D 1 primary_doc.xml X0708 D LIVE 0001953599 Inflection Point Genetics Inc. 4340 DUNCAN AVENUE SUITE 278 ST. LOUIS MO MISSOURI 63110 314-615-6355 DELAWARE None None Corporation true 2022 Edward Weinstein 4340 Duncan Avenue Suite 278 St. Louis MO MISSOURI 63110 Executive Officer Director Biotechnology Decline to Disclose 06b false 2022-10-24 false true false 15000 1000000 265005 734995 false 6 0 0 0 A portion of the proceeds will be used for general working capital, which may include salary payments to executive officers and directors. An estimate of such amount is unknown at this time. false Inflection Point Genetics Inc. William J. Vega William J. Vega Attorney-in-fact 2022-11-08